Search hospitals

>

Arizona

>

Tucson

University of Arizona

Claim this profile

Tucson, Arizona 85724

Global Leader in Cancer

Global Leader in Lung Cancer

Conducts research for Breast Cancer

Conducts research for Cystic Fibrosis

Conducts research for Lymphoma

413 reported clinical trials

61 medical researchers

Photo of University of Arizona in TucsonPhoto of University of Arizona in TucsonPhoto of University of Arizona in Tucson

Summary

University of Arizona is a medical facility located in Tucson, Arizona. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Cystic Fibrosis, Lymphoma and other specialties. University of Arizona is involved with conducting 413 clinical trials across 1,103 conditions. There are 61 research doctors associated with this hospital, such as Holly E. Pariury, Rachna Shroff, M.D., Pavani Chalasani, and Aaron Scott, MD.

Area of expertise

1

Cancer

Global Leader

University of Arizona has run 64 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage III
2

Lung Cancer

Global Leader

University of Arizona has run 48 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at University of Arizona

Lung Cancer

Breast Cancer

Cancer

Kidney Cancer

Testicular cancer

Stroke

Lazy Eye

Multiple Myeloma

Pancreatic Cancer

Colorectal Cancer

Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Image of trial facility.

High-Dose Radiation + Chemotherapy and Immunotherapy

for Non-Small Cell Lung Cancer

This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.

Recruiting

2 awards

Phase 3

14 criteria

Image of trial facility.

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.

Recruiting

2 awards

Phase 3

12 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Arizona?

Where is University of Arizona located?

Who should I call to ask about financial aid or insurance network?

What insurance does University of Arizona accept?

What awards or recognition has University of Arizona received?